XM does not provide services to residents of the United States of America.

Paint maker Akzo Nobel India's Q4 Profit Rises



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Paint maker Akzo Nobel India's Q4 Profit Rises</title></head><body>

May 15 (Reuters) -Paint maker Akzo Nobel India AKZO.NS reported a near 14% rise in its fourth-quarter profit on Thursday, aided by higher sales of its decorative paints.

The maker of Dulux paints reported a consolidated net profit of 1.09 billion rupees ($13.1 million) for the quarter ended March 31.

Revenue from operations rose 2% to 9.73 billion rupees.

For further result highlights, click [Full story]

KEY CONTEXT

Indian paint makers are facing a weak demand environment with consumers resorting to cheaper options, forcing larger players to cut prices to sustain their sales. Akzo Nobel India also flagged moderation in its volumes, but maintained better profit margin aided by favourable product mix across different categories.

Larger rival Asian Paints reported lower revenue in the March quarter and flagged lower demand in the premium segment of products, while Berger Paints BRGR.NS reported a marginal increase in revenue. Kansai Nerolac KANE.NS reported a 2% increase in revenue, while Indigo Paints INDG.NS is yet to report results.



PEER COMPARISON




Valuation (next 12 months)

Estimates (next 12 months)

Analysts' sentiment


RIC

PE

EV/EBITDA

Revenue growth (%)

profit growth (%)

Mean rating

# of analysts

Stock to price target

Div yield (%)

Akzo Nobel India Ltd

AKZO.NS

26.38

16.50

12.56

0.89

HOLD

1

0.86

3.52

Asian Paints Ltd

ASPN.NS

50.01

34.15

7.53

-1.68

HOLD

35

0.96

1.18

Kansai Nerolac Paints Ltd

KANE.NS

28.79

18.25

8.77

30.23

HOLD

11

0.85

0.91

Indigo Paints Ltd

INDG.NS

36.35

21.59

18.60

17.16

HOLD

6

0.84

0.26

* Mean of analysts' ratings standardised to a scale of Strong Buy, Buy, Hold, Sell, and Strong Sell

** Ratio of the stock's last close to analysts' mean price target; a ratio above 1 means the stock is trading above the PT




JANUARY-MARCH STOCK PERFORMANCE

-- All data from LSEG

-- $1 = 83.4859 Indian rupees



JANUARY-MARCH STOCK PERFORMANCE https://tmsnrt.rs/3V5D3hS


Reporting by Anisha Ajith in Bengaluru; Editing by Varun H K

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.